Key result
TUDCA improves endothelial dilation and reduces arterial stiffness in type 2 diabetic mice.
Why the study?
The importance of endoplasmic reticulum stress in diabetic vascular dysfunction is unclear.
Does tauroursodeoxycholic acid improve arterial stiffness and endothelial dysfunction in type 2 diabetic mice?
Does tauroursodeoxycholic acid improve arterial stiffness and endothelial dysfunction in type 2 diabetic mice?
Inhibition of ER stress with TUDCA improves endothelial dysfunction and reduces arterial stiffness in a mouse model of type 2 diabetes, suggesting a potential therapeutic target for diabetic vascular dysfunction.
Answers are grounded in this paper and cite their sources.
TUDCA may improve vascular function in diabetic mice; leaves open clinical translation of ER stress inhibition.
BACKGROUND/AIMS: Endoplasmic reticulum (ER) stress has emerged as a potential mechanism contributing to diabetes and its comorbidities. However, the importance of ER stress in diabetic vascular dysfunction is unclear. The purpose of this study was to examine the effects of the ER stress inhibitor, tauroursodeoxycholic acid (TUDCA), on arterial stiffness and endothelial dysfunction in type 2 diabetic mice. METHODS: Carotid and mesenteric artery endothelial function were assessed via ex vivo pressure myography, and arterial stiffness was measured by aortic pulse wave velocity. The effects of TUDCA were examined both acutely (ex vivo) and chronically (250 mg/kg/day; i.p., 4 weeks). RESULTS: Compared to control C57BL/6J mice, db/db (DB) mice did not display carotid artery endothelial dysfunction; however, mesenteric artery endothelial function was markedly impaired. Acute incubation and chronic administration of TUDCA improved endothelium-dependent dilation in DB mesenteric arteries, without affecting endothelium-independent dilation. Chronic TUDCA administration also reduced arterial stiffness and was associated with reductions in ER stress markers in aortic and perivascular adipose tissue. CONCLUSIONS: These results suggest that ER stress may represent a novel cause of, and therapeutic target for, diabetic vascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Battson et al. (2017) studied Type 2 diabetes. Tauroursodeoxycholic acid (TUDCA) vs. Control C57BL/6J mice / untreated DB mice was evaluated on Arterial stiffness and endothelial dysfunction. Acute incubation and chronic administration of TUDCA improved endothelium-dependent dilation in mesenteric arteries and reduced arterial stiffness in type 2 diabetic mice.
Synapse has enriched 10 related papers. Consider them for comparative context: